INTRODUCTION

TECHGEST 200MG contains Progesterone which belongs to the group of medicine called progestins. It is used in the prevention of endometrial hyperplasia (excessive thickening of uterine lining) in postmenopausal women with uterus who are receiving conjugated estrogens tablets as part of Hormone Replacement Therapy (HRT). It can also be used to treat progesterone imbalance states like pre-menstrual syndrome (PMS), benign mastopathies (a hormone-dependent change in glandular tissue in breasts) and symptoms of pre-menopause (such as hot flushes, anxiety, depression or vaginal dryness).

Premenstrual syndrome (PMS) is a combination of physical, emotional and psychological disturbances that occur during 7 to 10 days before their monthly period (after ovulation) and typically ends with the onset of menstrual flow. Common symptoms of PMS include tension, irritability, mood swings, depression, headache, breast tenderness, weight gain and bloating.

The most common side effects of taking this medicine are headache, dizziness, stomach pain, bloating and breast pain. Contact your doctor immediately, if you see any changes in breasts like dimpling of the skin, changes in the nipple or presence of any lumps. Avoid consumption of alcohol, driving or travelling, because this medicine may make you feel dizzy and drowsy. Take this medicine once daily preferably at bedtime. TECHGEST 200MG is considered safe for use during pregnancy. There are no evidence of impaired fertility or harm to the fetus due to the use of progesterone. However, consult your doctor before taking. This medicine is intended for use only in adult females and not recommended for use in children.

USES OF TECHGEST 200MG

• Prevents endometrial hyperplasia (excessive thickening of uterine lining) in postmenopausal women with uterus who are taking estrogens as part of Hormone Replacement Therapy (HRT)
• Treats benign mastopathies (a hormone-dependent change in glandular tissue in breasts)
• Treats symptoms of pre-menopause (such as hot flushes, anxiety, depression or vaginal dryness)

HOW TECHGEST 200MG WORKS

Progesterone taken orally, binds to and activates the progesterone receptor (PR) present in the stromal cells during the secretory phase of menstrual cycle and during pregnancy. It works by adjusting the hormonal balance within the body, restores progesterone levels in case of deficiency and reduce the symptoms associated with PMS, pre-menopause and benign mastopathies.

In patients receiving estrogen-based HRT, addition of progesterone helps to shed the excessive layers on the lining of the womb and prevents endometrial hyperplasia.

DIRECTIONS FOR USE

Take TECHGEST 200MG as directed by your physician. Take this medicine before meals. Swallow the medicine as a whole with a sip of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration of therapy for you depending upon your condition. Continue to take this medicine, as long as your doctor tells you to do so, to obtain better results.

SIDE EFFECTS OF TECHGEST 200MG

HOW TO MANAGE SIDE EFFECTS

Nausea or vomiting:

Try taking this medicine with, or just after meals. Stick to simple meals. Do not eat rich or spicy food.

Bloating or wind:

Eat smaller and frequent meals. Eat and drink slowly, and exercise regularly. If the symptoms get worse, contact your doctor immediately.

Abdominal cramps:

Try to rest and relax. You can eat and drink slowly or have smaller and frequent meals. Keeping a heat pad on your stomach may also help. If still pain persists, speak to your doctor.

Headache:  

Apply hot or cold-water bag on your head. Take rest in a quiet and dark room. Drink tea or coffee.

WARNING & PRECAUTIONS

INTERACTIONS

Talk to your doctor, if you are taking,

• medicines used to treat epilepsy (e.g. phenytoin, phenobarbital, carbamazepine)
• medicines used to treat tuberculosis (e.g. rifampicin, rifabutin)
• medicines used to treat HIV infection (e.g. nevirapine, efavirenz, ritonavir and nelfinavir)
• medicines used to prevent blood clots (e.g. coumarins, phenindone)
• medicines used to treat fungal infection (e.g. ketoconazole, griseofulvin or terbinafine)
• medicines used to treat diabetes (e.g. insulin, metformin)
• St. John’s Wart (a herbal medicine to treat depression)
• bromocriptine (used to treat problems of pituitary gland or Parkinson’s disease)
• ciclosporin (used to suppress immune system)
• spironolactone (a diuretic pill)
• antibiotics such as ampicillin, tetracyclines
• other progestins (e.g. medroxyprogesterone acetate, megestrol)
• ulipristal acetate (emergency contraceptive pill)
• diazepam (used to induce sleep)
• tizanidine (used to treat multiple sclerosis)

SYNOPSIS

MORE INFORMATION

Store below 20-25°C and keep out of reach of children.

FAQs ABOUT TECHGEST 200MG

Can TECHGEST 200MG cause miscarriage?

Currently, there is no evidence that progesterone as oral medication can cause miscarriage. If you are experiencing any unusual symptoms after taking this medicine, contact your doctor.

Can TECHGEST 200MG cause headache?

Yes. This medicine can cause headache in some individuals, although not everybody gets them. Rest and drink plenty of fluids. Do not drink too much alcohol. If the symptom persists, contact your doctor.

REFERENCES

1. KD. Tripathi. Hormones and related drugs: Estrogens, Progestins and Contraceptives. Essentials of medical pharmacology. Seventh edition. 2013. Page – 316-319.

2. Ellis R. Levin and Stephen R. Hammes. Estrogens and Progestins. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 12th Edition. New York McGraw Hill Medical 2011. Page – 1180-1184.

3. University of British Columbia. Progesterone for Perimenopausal Night Sweats. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on December 2019] [Accessed 10th November 2020] https://clinicaltrials.gov/ct2/show/NCT01464697

4. IBSA Institut Biochimique SA. Efficacy Study of Progesterone Tablet in Post-menopausal Women. NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised on June 2018] [Accessed 10th November 2020] https://clinicaltrials.gov/ct2/show/NCT02841137

5. Katrina Wyatt, Paul Dimmock, Peter Jones, Manjit Obhrai, and Shaughn O'Brien. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. NCBI; PMC National Library of Medicine, National Institute of Health. October 2001. [Accessed 10th November 2020] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC57352/

6. D L Moyer, B de Lignieres, P Driguez, J P Pez. Prevention of endometrial hyperplasia by progesterone during long-term estradiol replacement: influence of bleeding pattern and secretory changes. NIH National Library of Medicine, National Centere of Biotechnology Information. Pubmed.gov. May 1993. [Accessed 10th November] https://pubmed.ncbi.nlm.nih.gov/8486201/#:~:text=Conclusions%3A%20Control%20of%20endometrial%20growth,benefit%20for%20prevention%20of%20hyperplasia.

7. Ciplamed. Endogest capsules (micronized progesterone). Ciplamed.com [Revised on December 2015] [Accessed 10th November 2020] https://www.ciplamed.com/content/endogest-capsules

8. Catalent Pharma Solutions. U.S. Food & Drug Administration. 2011. [Accessed 9th November 2020] https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019781s017,020843s011lbl.pdf

9. Besins Manufacturing Belgium. Electronic Medicines Compendium (EMC); [Revised on May 2020] [Accessed 9th November 2020] https://www.medicines.org.uk/emc/files/pil.352.pdf

USEFUL DIAGNOSTIC TESTS

• Anti-Mullerian Hormone
• Glycosylated Hemoglobin
• Testosterone Total
• Thyroid Stimulating Hormone